Sign inJoin waitlistJoin the waitlist

NJ

Nalini Janakiraman

Hematology & Oncology

Credentials: ·

History

Hematology and Medical Oncology
1970–1973
Internal Medicine
1967–1970
Medical School
1963–1967

Research

IDEC-C2B8 (Rituximab) anti-CD20 monoclonal antibody therapy in patients with relapsed low-grade non-Hodgkin's lymphoma
Blood · 1997 · 1,358 citations
Phase I/II trial of IDEC-Y2B8 radioimmunotherapy for treatment of relapsed or refractory CD20(+) B-cell non-Hodgkin's lymphoma
Journal of Clinical Oncology · 1999 · 441 citations
Extended Rituximab (anti-CD20 monoclonal antibody) therapy for relapsed or refractory low-grade or follicular non-Hodgkin's lymphoma
Annals of Oncology · 1999 · 317 citations

RC
Robert Chapman
17 papers
JM
Javier Munoz
4 papers · 4 as a fellow
Ajay Nooka
3 papers
Ann Mohrbacher
3 papers
CH
Carol Huff
3 papers
Edward Peres
3 papers
HT
Howard Terebelo
3 papers
Jayesh Mehta
3 papers
Jeffrey Zonder
3 papers
LB
Leon Bernal-Mizrachi
3 papers
Ravi Vij
3 papers
Robert Orlowski
3 papers